Work

Rare Presentation of Adult‐Onset Still's Disease Complicated by Acute Severe Hepatitis Refractory to Medical Treatment: A Case Report

Year: 2025

Type: article

Abstract: ABSTRACT Managing adult‐onset Still's disease complicated by severe hepatitis requires vigilant monitoring and adaptable therapeutic strategies. Standard treatments such as tocilizumab and rituximab can cause adverse reactions or lose efficacy. The interplay of systemic inflammation and liver involvement highlights the need for ongoing research to find effective, safe treatment alternatives.

Source: Clinical Case Reports

DOI: 10.1002/ccr3.70629

Authors: Majed Ali, Karam Karam, Emanuel‐Youssef Dib, Elias Fiani

Institution: University of Balamand

Language: English

Topic: Autoimmune and Inflammatory Disorders Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,820